Bioventus Investor

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely.

Invests into

Technology: Predictive Medicine
Industry: P4 Medicine
Headquarters: Durham, North Carolina, United States
Founded Date: 2012-01-01
Employees Number: 251-500
Investor Type: For Profit
Number Of Exits: 1
Acquisitions Number: 1
Investors Number: 7
Total Funding: 545000000
Estimated Revenue: $100M to $500M
Last Funding Date: 2022-04-26
Last Funding Type: Post-IPO Debt

Visit Website
biologics.communications@bioventusglobal.com
http://twitter.com/BioventusGlobal
Register and Claim Ownership